Article · 2018
Editorial Board Member
Gregory Lee
The University of British Columbia, Canada
About
As published by the journal they serve.
Gregory Lee was professor at University of British Columbia in Vancouver, Canada until 2012. He received his PhD in physical biochemistry from California Institute of Technology Pasadena, CA in 1972. His major research interest is in the field of biotechnology. He has generated numerous monoclonal antibodies for immunodiagnostic and therapeutic applications, including the early pregnancy detection, ovulation, myocardial infarction and cancer. During the last decade, he has been focused on research and development of the monoclonal antibody-based anti-cancer drugs (noticeably RP215 and GHR106) for immunotherapy of human cancer. He has been serving as editors of several international journals related to cancer research since 2012.
Research interests
Journals they serve
The seats these journals name them in.
- Journal of Tumor ResearchEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2018
Cancerous immunoglobulins and potential clinical applications
Article · 2018
Anti-GnRH receptor monoclonal antibodies are long acting biosimilar GnRH antagonists
Article · 2015
Anti-GNRH receptor monoclonal antibodies as bioequivalent analogs of GNRH
Article · 2015
First-in-class GnRH analog for cancer therapy
Article · 2013
Carbohydrate-associated epitope-based anti-cancer drugs and vaccines
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.